Latest News

The YSPH community came together on May 13th to recognize faculty and staff excellence, and to unveil its new ceremonial mace.

Yale researchers worked with residents of New Haven’s Dwight neighborhood to document the impact of urban heat and identify community-informed solutions.

Hundreds of Pakistani children received contaminated shots at a state hospital — and officials keep looking the other way

Early exposure to PFAS, a group of widely used compounds known as "forever chemicals," was associated with a higher risk of acute lymphoblastic leukemia, the most common childhood cancer, according to University of California, Irvine Joe C. Wen School of Population & Public Health researchers.

“What are you going to do when you go back?” It’s the question that set Jeannette Ickovics, PhD, a faculty affiliate at the Yale Institute of Global Health (YIGH), on a new trajectory toward global climate and health. After nearly five years at Yale-NUS College in Singapore, first as a visiting professor and later as dean of faculty, Ickovics found herself reflecting on what the next phase of her career might look like upon returning to New Haven.

You probably can’t keep every tick off your property, but there are ways to deter them — which could help reduce the risk of tick-borne diseases such as Lyme.

Scientists at Yale School of Public Health have developed a process that could lead to a better understanding of how brain function links to behavior. In a separate report, YSPH scientists say that recent changes to Medicare Advantage plans are improving care for people with dementia.

Specialized emergency departments for geriatric patients are a promising and potentially life-saving model of care, according to a new YSPH study. But as their use expands across the country, policymakers must tackle deeper inequities that are preventing all older adults from benefiting equally from the targeted care.

A new study led by researchers at the Yale School of Public Health finds that Alzheimer’s disease clinical trials in the U.S. have consistently failed to reflect the nation’s racial and ethnic diversity, raising important concerns about whether new treatments are equally safe and effective for all patients.